 |
|
Hypermagnesemia: Elderly Over-the-counter Drug Users at Risk
Michael Shechter, MD, MA
Arch Fam Med. 1996;5(6):323.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Fung MC, Weintraub M, Bowen DL. Hypermagnesemia: elderly over-thecounter drug users at risk. Arch Fam Med. 1995;4:718-723.
FREE FULL TEXT
2. Wallach J. Creatinine clearance. In: Wallach J. Interpretation of Diagnostic Tests. 4th ed. Boston, Mass: Little Brown & Co; 1986:106-107. 3. Rude RK, Bethune JE, Singer FR. Renal tubular maximum for magnesium in normal, hyperparathyroid and hypoparathyroid men. J Clin Endocrinol Metab. 1980;51:1425-1431.
FREE FULL TEXT
4. Rude RK. Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. Am J Cardiol. 1989;63(suppl):31G-34G.
PUBMED
5. Shechter M, Kaplinsky E, Rabinowitz B. The rationale for magnesium supplementation in acute myocardial infarction. Arch Intern Med. 1992;152:2189-2196.
FREE FULL TEXT
6. ISIS-4 Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
PUBMED
7. Seelig MS. Possible roles of magnesium in disorders of the aged. In: Regelson W, Sinex FM, eds. Intervention in the Aging Process, Part A: Quantitation, Epidemiology, Clinical Research. New York, NY: AR Liss Inc; 1983:279-305. 8. Mountakalakis TD. Effects of aging, chronic disease, and multiple supplements on magnesium requirements. Magnesium. 1987;6:5-11.
PUBMED
9. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations: magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989;63(suppl):4G-21G.
PUBMED
|
